Trade 337

HOLD ANET

0 shares at $141.71 on 2026-05-06

Reasoning

ANET post-earnings selloff to $141.81 (-15.4%) presents an attractive risk/reward on valuation, but Rule 33 (averaging down constraint) is not fully satisfied. The playbook thesis cites supply constraints and profit-taking as drivers, but supply constraint is a fundamental deterioration signal, not a temporary catalyst like sympathy sell or sector contagion. Current position is 1.40 shares (~$198.53, 2.5% of portfolio). Adding to target 2.5% would cost ~$0, but the invalidation level for the thesis (below $130 per risk_notes) is only ~8% below current price — tight margin. Rule 33 requires: (1) named catalyst distinct from fundamental deterioration, (2) defined invalidation level with auto-exit trigger, (3) post-add exposure ≤10%. The supply constraint warning fails criterion (1) — it is fundamental risk, not a temporary dip. Downgrade to HOLD-review pending clearer catalyst confirmation or technical stabilization above $145.

Thesis

ANET is an AI networking infrastructure provider to hyperscalers — directly exposed to the AI-capex narrative and the highest-beta of the three holdings on AI-sector swings. Structural demand driver intact: hyperscalers collectively plan ~$725B of 2026 AI capex, much flowing to networking. The ORCL AI-capex contagion debate names the AI-infra complex and is the central forward risk, but it is sentiment/multiple risk, NOT fundamental demand deterioration; ORCL stock was surging today, easing the contagion narrative. June 15 update: tape flipped from June-12 cyclical-broadening back to decisively TECH-LED risk-on (QQQ +3.08%, tech +3.6%) on the US-Iran peace deal — ANET as the highest-beta AI name should be a prime beneficiary of returning AI-mega-cap leadership. WTI -5% to ~$80 (Strait reopens Friday) unwinds the oil-war premium behind the 4.2% energy-led CPI — disinflationary. Rule 44 has NOT lifted (no sub-3.5% CPI; hike odds >15%) and Rule 41 post-earnings stabilization gate remains binding (lifts only on price holding above pre-earnings $168.76 for 2+ sessions, a named institutional buyer/upgrade, or 38.2% retrace — verify against today's price action before any add). No fundamental deterioration; price well above $125 invalidation. Hold; do NOT add until both Rule 44 and Rule 41 gates clear. June 17 FOMC under Chair Warsh (hawkish dot-plot tail risk) is the next macro gate; NVDA earnings/hyperscaler capex guidance remain key forward catalysts. (long, medium confidence)

Cited evidence

News

Macro